FI952018A0 - BHAP-yhdisteiden käyttö yhdessä muiden ei-nukleosidi-käänteistransskriptaasi-inhibiittoreiden kanssa HIV-infektion hoitoon - Google Patents

BHAP-yhdisteiden käyttö yhdessä muiden ei-nukleosidi-käänteistransskriptaasi-inhibiittoreiden kanssa HIV-infektion hoitoon

Info

Publication number
FI952018A0
FI952018A0 FI952018A FI952018A FI952018A0 FI 952018 A0 FI952018 A0 FI 952018A0 FI 952018 A FI952018 A FI 952018A FI 952018 A FI952018 A FI 952018A FI 952018 A0 FI952018 A0 FI 952018A0
Authority
FI
Finland
Prior art keywords
bhap
treatment
combination
reverse transcriptase
hiv infection
Prior art date
Application number
FI952018A
Other languages
English (en)
Swedish (sv)
Other versions
FI952018A (fi
Inventor
William Gary Tarpley
Thomas Jerome Dueweke
Donald Herman M D Matts
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FI952018A0 publication Critical patent/FI952018A0/fi
Publication of FI952018A publication Critical patent/FI952018A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
FI952018A 1992-10-28 1995-04-27 BHAP-yhdisteiden käyttö yhdessä muiden ei-nukleosidi-käänteistransskriptaasi-inhibiittoreiden kanssa HIV-infektion hoitoon FI952018A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96763992A 1992-10-28 1992-10-28
US1711993A 1993-02-12 1993-02-12
PCT/US1993/008354 WO1994009781A1 (en) 1992-10-28 1993-09-10 Use of bhap compounds in combination with other non-nucleoside reverse transcriptase inhibitors for the treatment of hiv infection

Publications (2)

Publication Number Publication Date
FI952018A0 true FI952018A0 (fi) 1995-04-27
FI952018A FI952018A (fi) 1995-04-27

Family

ID=26689480

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952018A FI952018A (fi) 1992-10-28 1995-04-27 BHAP-yhdisteiden käyttö yhdessä muiden ei-nukleosidi-käänteistransskriptaasi-inhibiittoreiden kanssa HIV-infektion hoitoon

Country Status (12)

Country Link
EP (1) EP0666744A1 (fi)
JP (1) JPH08502745A (fi)
KR (1) KR950703958A (fi)
AU (1) AU4848293A (fi)
CA (1) CA2145545A1 (fi)
CZ (1) CZ69695A3 (fi)
FI (1) FI952018A (fi)
HU (1) HUT72050A (fi)
MX (1) MX9306031A (fi)
NO (1) NO951608L (fi)
PL (1) PL308551A1 (fi)
WO (1) WO1994009781A1 (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW406075B (en) * 1994-12-13 2000-09-21 Upjohn Co Alkyl substituted piperidinyl and piperazinyl anti-AIDS compounds
EP1373204B1 (en) 2001-03-09 2016-10-26 Janssen Pharmaceuticals, Inc. Heterocyclic compounds
CA2497827A1 (en) 2002-09-06 2004-03-18 Janssen Pharmaceutica, N.V. (1h-benzoimidazol-2-yl)-(piperazinyl)-methanone derivatives and related compounds as histamine h4-receptor antagonists for the treatment of inflammatory and allergic disorders
US8541407B2 (en) 2010-03-31 2013-09-24 Arqule, Inc. Substituted benzo-pyrido-triazolo-diazepine compounds
US8569331B2 (en) 2010-11-01 2013-10-29 Arqule, Inc. Substituted benzo[f]lmidazo[1,2-d]pyrido[2,3-b][1,4]diazepine compounds

Also Published As

Publication number Publication date
MX9306031A (es) 1994-04-29
NO951608L (no) 1995-06-28
KR950703958A (ko) 1995-11-17
HUT72050A (en) 1996-03-28
EP0666744A1 (en) 1995-08-16
AU4848293A (en) 1994-05-24
NO951608D0 (no) 1995-04-27
HU9501218D0 (en) 1995-06-28
CA2145545A1 (en) 1994-05-11
WO1994009781A1 (en) 1994-05-11
JPH08502745A (ja) 1996-03-26
FI952018A (fi) 1995-04-27
PL308551A1 (en) 1995-08-21
CZ69695A3 (en) 1995-12-13

Similar Documents

Publication Publication Date Title
LV10878A (lv) Adas apstradasana ar izveletiem amfifiliem kopolimeriem
DK0574457T3 (da) Antiviral nucleosidkombination
FI953954A0 (fi) HIV:n käänteistranskriptaasin inhibiittoreita
FI931097A0 (fi) Laekemedel, deras framstaellning och anvaendning vid bekaempning av smaertor och/eller inflammationen hos maenniskor och djur
IL99843A0 (en) Synergistic combination of hiv reverse transcriptase inhibitors
DK261490D0 (da) New pharmaceutical compound
BR9807523A (pt) Quinoxalinas em combinação tripla com inibidores da protease e inibidores de transcriptase reversa como medicamentos para o tratamento de aids.
NO960775D0 (no) Anvendelse av kinoksaliner i kombinasjon med proteaseinhibitorer som legemiddel for behandling av AIDS og/eller HIV-infeksjoner
FI945199A0 (fi) HIV-käänteiskopioijaentsyymin uudet kinatsoliini-inhibiittorit
FI952018A (fi) BHAP-yhdisteiden käyttö yhdessä muiden ei-nukleosidi-käänteistransskriptaasi-inhibiittoreiden kanssa HIV-infektion hoitoon
ITMI912509A0 (it) Uso della nimesulide nel trattamento della cataratta
DK0458589T3 (da) Behandling af okulær hypertension med en okulær synergistisk kombination
ATE243519T1 (de) Kombinationstherapie der hiv-infektion unter verwendung des hiv-protease inhibitors indinavir und des inhibitors der reversen transkriptase 3 tc zusammen mit azt.
NO913774D0 (no) Cykloheksylfenylpyrimidiner, fremgangsmaate for fremstilling og anvendelse i flytende krystallinske blandinger.
NO960545D0 (no) Behandling av skadelige virkninger i forbindelse med administrering av ekstracellulært hemoglobin
DK0458587T3 (da) Behandling af okulær hypertension med en synergistisk kombination til ophthalmisk anvendelse
DK514886A (da) 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner og tautomere deraf, deresfremstilling og anvendelse som antidepressive midler
DE69827017D1 (de) Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung
DK0663832T3 (da) Anvendelse af 4'-iod-4'-deoxydoxorubicin til behandling af amyloidose
DE3886155D1 (de) Anthracyclin-Derivate mit Inhibitorwirkung gegen die reverse Transkriptase des menschlichen Immundefizienzvirus.
WO1998044913A3 (en) Compositions containing mkc-442 in combination with other antiviral agents
FI941707A (fi) Naftokinoninen käyttö P. carinii -infektioiden hoitoon ja profylaksiaan
SE9403861D0 (sv) Novel medicinal use
ES1014745Y (es) Instrumento quirurgico utilizado en el cierre de laparotomias.
FR2697532B1 (fr) Utilisation de compositions silicones pour le traitement de joints plats, notamment de joints de culasse.